| 项目编号 |
PRJCA050142 |
| 项目标题 |
Qingfei Dayuan Granules and Decoction Alleviate Acute Lung Injury via TLR4 Signaling Pathway Modulation, Gut Microbiota Regulation, and Metabolic Reprogramming |
| 涉及领域 |
Medical |
| 数据类型 |
Metabonomics
Metabonomics
|
| 物种名称 |
|
| 描述信息 |
To explore and compare the therapeutic effects and underlying mechanisms of Qingfei Dayuan Granules (QFDYGs) and Qingfei Dayuan Decoctions (QFDYDs) for the treatment of acute lung injury (ALI), focusing on the modulation of the TLR4 signaling pathway, intestinal microbiota, and related metabolic pathways. |
| 样品范围 |
Monoisolate |
| 发布日期 |
2025-11-04 |
| 出版信息 |
| PubMed ID |
文章标题 |
杂志名称 |
Doi |
发表年份 |
| 41311834
|
Qingfei Dayuan granules and decoction alleviate acute lung injury via TLR4 signaling pathway modulation, gut microbiota regulation, and metabolic reprogramming
|
Frontiers in Pharmacology
|
10.3389/fphar.2025.1643544
|
2025
|
|
|
| 项目资金来源 |
| 机构 |
项目类型 |
授权项目ID |
授权项目名称 |
| Hubei Science and Technology Major Project
|
|
2022ACA003
|
|
|
|
| 提交者 |
Huanbo
Cheng (121881467@qq.com)
|
| 提交单位 |
Affiliated Hospital of Hubei University of Chinese Medicine |
| 提交日期 |
2025-11-04 |
